Product catalog
contact us

    KCI BioTech (Suzhou) Inc.
    Tel:0512-69998806
    Ministry of Commerce:0512-69998806-8012
    BD:
    East and South China:Ms. Gu 15378638068
    North China, East China:Mr. Han 18914988667
    Central and Western regions: Ms. Xiang 15828112963
    Project Management Department:0512-69998806-8022
    Tumor business:0512-69998806-8058
    Non tumor business:0512-69998806-8026
    Pathogenic microorganism business:0512-69998806-8037
    Integrated Service Platform:0512-69998806-8022
    Address: Building A2, Xinyang Industrial Park, No. 8 Yanghua Road, Suzhou Industrial Park

Key model for drug development of primary biliary cholangitis

  Primary biliary cholangitis (PBC), also known as primary biliary cirrhosis, is an organ-specific, chronic cholestatic autoimmune liver disease. The disease is notably characterized by intrahepatic cholestasis, the presence of antimitochondrial antibodies in the circulating blood, and progressive, non-suppurative inflammatory destruction of the small intrahepatic bile ducts, which ultimately leads to extensive hepatic ductal destruction, biliary cirrhosis, and even liver failure.
  We have established a stable model of bile duct ligation-induced primary biliary cholangitis and a model of α-naphthyl isothiocyanate (ANIT)-induced primary biliary cholangitis, which are suitable for the study of drugs for preclinical primary biliary cholangitis and the evaluation of new drugs.
  If you have project needs and experience more of our professional services, please contact us.

Our services

Model classification

Model Name

Animal species

Primary biliary cholangitis

Model of primary biliary cholangitis induced by bile duct ligation

Mice,rats

Model of primary biliary cholangitis induced by alpha-naphthyl isothiocyanate (ANIT)

Mice,rats


Case sharing

Next:Primary sclerosing cholangitis